Highlights Basilea Pharmaceutica AG OTC Markets

Equities

BPMUF

CH0011432447

Market Closed - OTC Markets Other stock markets 13:51:48 2024-05-20 EDT			5-day change	1st Jan Change
48.15 ^USD	+8.32%		0.00%	+17.44%

05-16	Basilea Pharmaceutica Receives Milestone Payment from Pfizer for Cresemba Sales	MT
05-16	Strong Cresemba(R) (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea	DJ

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Basilea Pharmaceutica Receives Milestone Payment from Pfizer for Cresemba Sales	05-16	MT
Strong Cresemba(R) (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea	05-16	DJ
Basilea Reports Presentation of New Data for Ceftobiprole (Zevtera®) At Escmid Global 2024	05-03	CI
Basilea Pharmaceutica Receives Grant for Antibiotics Program	04-09	MT
Stocks Close in Green as Swiss Inflation Unexpectedly Slows	04-04	MT
US FDA approves Basilea Pharmaceutica's antibiotic	04-03	RE
US FDA approves Basilea Pharmaceutica's antibiotic	04-03	RE
Continued strong Cresemba(R) (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea	03-11	DJ
Basilea Pharmaceutica AG Provides Earnings Guidance for the Year 2024	02-13	CI
Basilea Pharmaceutica AG Reports Earnings Results for the Full Year Ended December 31, 2023	02-13	CI
Basilea Pharmaceutica Posts Lower FY23 Net Profit; Revenue Up	02-13	MT
Basilea reports strong 2023 full-year results with profitability significantly above guidance, whilst substantially expanding the R&D portfolio	02-13	DJ
Spexis Completes CHF2 Million Sale of Antibiotics Program to Basilea	02-08	MT
Cresemba(R) sales in Latin America trigger first sales milestone payment to Basilea	01-19	DJ
Basilea Pharmaceutica to Buy Preclinical Antibiotics Program Targeting Gram-negative Bacteria from Spexis	01-15	MT
Basilea announces acquisition of preclinical antibiotics program from Spexis	01-15	DJ
Basilea Pharmaceutica Eyes Commercialization Partner for Ceftobiprole Ahead of US FDA Verdict	01-05	MT
Basilea provides portfolio status update	01-05	DJ
Basilea announces accelerated loan repayment	12-20	DJ
Basilea to Get $1 Million Sales Milestone Payment from Pfizer for Antifungal Drug	11-20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Basilea Pharmaceutica AG OTC Markets

Equities

BPMUF

CH0011432447

Highlights

Filters